🇺🇸 FDA
Patent

US 8349371

Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosphorylation of mitogen-activated protein kinase using neonauclea reticulata leaf extracts

granted A61KA61K2236/30A61K36/74

Quick answer

US patent 8349371 (Method for anti-oxidation, inhibiting activity and/or expression of matrix metalloproteinase, and/or inhibiting phosphorylation of mitogen-activated protein kinase using neonauclea reticulata leaf extracts) held by China Medical University expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2236/30, A61K36/74, A61P, A61P17/00